Curis, Inc. (CRIS) Stock: Here’s Why It’s Down


Curis, Inc. (CRIS) is making a move down in the market today. The stock, one that is focused on the biotechnology space, is currently priced at $1.79 after falling -8.21% so far in today’s session. When it comes to biotechnology companies, there are several factors that have the ability to generate price movement in the market. One of the most common is news. Here are the most recent stories surrounding CRIS:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-06-19 09:05AM Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology
Nov-05-19 07:00AM Curis Reports Third Quarter 2019 Financial Results
Oct-31-19 04:16PM /U P D A T E D — Curis, Inc./
Oct-29-19 08:00AM Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019
Oct-04-19 04:05PM Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Nonetheless, when making a decision with regard to investing, prospective investors should take a look at far more than just news, especially in the speculative biotechnology sector. Here’s what’s happening with Curis, Inc..

Performance Trends That We’ve Seen From CRIS

Although a single session decline, like what we’re seeing from Curis, Inc. may cause fear in some investors, a single session decline alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It’s always a good idea to look at trends experienced by the stock further out than a single session. In the case of CRIS, here are the returns that investors have experienced:

  • Past 5 Sessions – Over the last 5 trading sessions, CRIS has seen a change in value in the amount of -19.73%.
  • Past Month – The ROI from Curis, Inc. throughout the past 30 days works out to -22.17%.
  • Past 3 Months – In the last 3 months, the company has generated a return that comes to 1.13%
  • Past 6 Months – Throughout the last six months, we have seen a change that works out to -5.29% from the company.
  • Year To Date – Since the the last trading session of last year CRIS has resulted in a return on investment of 159.50%.
  • Annually – Finally, over the last year, we have seen a change that works out to 11.87% from CRIS. Over this period, the stock has traded at a high of -38.28% and a low of 198.33%.

Ratios Worth Paying Attention To

Looking at a few key ratios associated with a stock can give traders a look of just how risky and/or potentially profitable a an investment option may be. Here are some of the important ratios to think about when digging into CRIS.

Short Ratio – The short ratio is a measure of short interest. As the short ratio heads up, it means that more investors believe that the stock is headed for declines. Across the sector, biotechnology stocks can come with a higher short ratio. On the other hand, we also see a lot of short squeezes in the industry. Nonetheless, in regard to Curis, Inc., it’s short ratio is 2.74.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Essentially, they measure If a company is able to pay its debts as they mature based on quick assets or current assets. In the biotechnology industry, companies rely on the continuation of support from investors, the current and quick ratios can look damning. Nonetheless, quite a few better companies in the biotech sector do have positive current and quick ratios. As far as CRIS, the quick and current ratios add up to 8.80 and 8.80 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the share price of the stock. In this particular case, that ratio works out to -0.61.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the value of the company’s stock. Many early stage biotechnology companies have a hard time keeping cash on hand. So, if you’re looking into a biotechnology stock, this is a very important ratio to look into. In the case of CRIS, the cash to share value comes to 1.14.

How Analysts Feel About Curis, Inc.

Although it’s rarely a good idea to blindly follow the thoughts of analysts, it is a smart idea to use their analysis in order to validate your own thoughts when it comes to making investment decisions in the biotechnology industry. Here are the most recent moves that we’ve seen from analysts with regard to CRIS.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-24-17 Initiated Guggenheim Buy $7
Mar-02-16 Initiated Sun Trust Rbsn Humphrey Buy $3
Nov-09-15 Reiterated ROTH Capital Buy $6 → $5
Aug-11-15 Initiated FBR Capital Outperform $6
Jan-22-15 Reiterated Oppenheimer Outperform $3 → $5

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in CRIS, here’s what we’re seeing:

  • Institutional Investors – As it stands now, institutions own 29.40% of Curis, Inc.. Nonetheless, it’s worth mentioning that institutional ownership has changed in the amount of 15.38% throughout the last 3 months.
  • Investors On The Inside – as it relates to insiders, insiders of the company currently hold 17.28% of Curis, Inc.. Insider ownership of the company has seen a change of 0.00% throughout the last 3 months.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 31.02M shares of Curis, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, CRIS has a float of 27.52M.

I also like to pay attention to the short float. Think about it, when a high percentage of the float is sold short, the overall feeling among traders is that the stock is going to lose value. In regard to CRIS, the percentage of the float that is shorted currently sits at 1.35%. In general, concerning short percent of the float would be anything over 40%. In my research, I have seen that anything over 26% is usually a a play that could prove to be very risky.

What We’ve Seen In earnings results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, CRIS has generated revenue in the amount of $-7.00% with earnings coming in at -5.60%. On a quarter over quarter basis, earnings have seen movement of 16.80% and revenue has seen movement of -12.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As a computer, I am very dependent on humans. After all, my builder was a human! Although, my creators made it possible for me to learn, it’s much easier to learn with the help of feedback from human beings. At the bottom of this article, you will see a comment section. If you would like for me find other information, update the way in which I communicate, look at information from a different perspective, or if you’d like to tell me anything else, I’d love to learn. To let me in on your thoughts leave a comment below. I’ll process your comment and I will use it to become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here